Investor Presentation • Feb 11, 2021
Investor Presentation
Open in ViewerOpens in native device viewer

The information contained herein in this presentation or delivered or to be delivered to you during our presentation does not constitute an offer, expressed or implied, or a recommendation to do any transaction in ICL Group Ltd. (ICL Group or Company)securities or in any securities of its affiliates or subsidiaries.
This presentation and/or other oral or written statements made by ICL Group during its presentation or from time to time, may contain forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 and other applicable securities laws. Whenever words such as "believe," "expect," "anticipate," "intend," "plan," "estimate", "predict" or similar expressions are used, the Company is making forward-looking statements. Such forward-looking statements may include, but are not limited to, our 2021 guidance, those that discuss strategies, goals, financial outlooks, corporate initiatives, existing or new products, existing or new markets, operating efficiencies, or other non-historical matters.
Because such statements deal with future events and are based on ICL Group's current expectations, they could be impacted or be subject to various risks and uncertainties, including those discussed in the "Risk Factors" section and elsewhere in our Annual Report on Form 20-F for the year ended December 31, 2020, and in subsequent filings with the Tel Aviv Securities Exchange (TASE) and/or the U.S. Securities and Exchange Commission (SEC). Therefore, actualresults, performance or achievements of the Company could differ materially from those described in or implied by such forward-looking statements.
Although the Company believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can provide no assurance that expectations will be achieved. Except as otherwise required by law, ICL Group disclaims any intention or obligation to update or revise any forward-looking statements, which speak only as of the date hereof, whether as a result of new information, future events or circumstances or otherwise. Readers, listeners and viewers are cautioned to consider these risks and uncertainties and to not place undue reliance on such information.
Certain market and/or industry data used in this presentation were obtained from internal estimates and studies, where appropriate, as well as from market research and publicly available information. Such information may include data obtained from sources believed to be reliable, however ICL Group disclaims the accuracy and completeness of such information which is not guaranteed. Internal estimates and studies, which we believe to be reliable, have not been independently verified. We cannot assure that such data is accurate or complete.
Included in this presentation are certain non-GAAP financial measures, such as adjusted operating income, adjusted EBITDA, adjusted net income, adjusted EPS, segment EBITDA, segment EBITDA margin and free cash flow, designed to complement the financial information presented in accordance with IFRS because management believes such measures are useful to investors. Please note that other companies may calculate similarly titled non-GAAP financial measures differently than ICL Group and that our definitions of these measures may differ from those used by other companies or such companies may use other measures to evaluate their performance, which may reduce the usefulness of our non-GAAP financial measures as tools for comparison. These non-GAAP financial measures should be considered only as supplemental to, and not superior to, financial measures provided in accordance with IFRS. Please refer to our fourth quarter 2020 press release for the period ended December 31, 2020 and the appendix to this presentation for a reconciliation of the non-GAAP financial measuresincluded in this presentation to the most directly comparable financialmeasures prepared in accordance with IFRS.
2


Improved sales and operating income driven by all four divisions


| US\$M | 4Q'20 | 4Q'19 | YoY Chg. | FY'20 | FY'19 | YoY Chg. |
|---|---|---|---|---|---|---|
| Sales | \$1,317 | \$1,106 | +19% | \$5,043 | \$5,271 | -4% |
| Operating income | \$139 | \$88 | +58% | \$202 | \$756 | -73% |
| • Adjusted operating income(1) |
\$143 | \$88 | +63% | \$509 | \$760 | -33% |
| Net income, attributable | \$65 | \$48 | +35% | \$11 | \$475 | -98% |
| • Adjusted net income(1) |
\$68 | \$48 | +42% | \$258 | \$479 | -46% |
| Adjusted EBITDA(1) | \$268 | \$201 | +33% | \$990 | \$1,198 | -17% |
| Operating cash flow | \$258 | \$212 | +22% | \$804 | \$992 | -19% |

(1) Adjusted operating income, adjusted net income and adjusted EBITDA are non-GAAP financial measures; see reconciliation tables in appendix.
Record sales and operating income in 4Q'20




• Improvement due to record production, compared with three-
• ICL Iberia: ramp connected, with consolidation expected to

• ICL Boulby: record production of Polysulphate, our one-of-a-kind
FY'20
• Average realized price per tonne for potash down 17% YoY

Record specialties and YPH operating income for FY'20

• Specialties sales up 11% YoY, with record operating income


Record 4Q'20 operating income capped a record year

‐ Positive quarterly results, despite seasonality, helped drive growth in annual operating income – up 91%
‐ Benefitted from cost efficiencies, lower raw material costs,
• Specialty agriculture seeing strong demand across all regions

‐ Strong demand for both Turf and Landscape and
‐ Growth in Europe, North America, Australia, New Zealand




Gained good momentum, with all divisions contributing to 4Q'20 sales and operating income improvement
Starting 2021 on solid footing, expect worst of 2020 behind us and commodity prices to remain in our favor
Strategic actionsin 2020 helped set stage for 2021 and beyond
Internal innovation added \$40M run rate to profitability, coming out of 2020
Cost efficiencies of more than \$80M in 2020 expected to benefit 2021
Maintained strong balance sheet, expected to provide flexibility for 2021



Record liquidity of +\$1B available – provides flexibility for M&A
Operating cash flow of \$804M
Free cash flow(1) of \$188M
Net debt to EBITDA 2.5 times
Debt extended more than \$200M to long-term, due past 2030

(1) Free cash flow is a non-GAAP financial measure; see reconciliation tables in appendix.




(1) Adjusted EBITDA is a non-GAAP financial measures; see reconciliation tables in appendix. Note: Numbers rounded to closest million.





(1) Adjusted EBITDA is a non-GAAP financial measures; see reconciliation tables in appendix. Note: Numbers rounded to closest million.
• 20 global R&D centers, 250 patent families – with 850
• Focused and highly experienced technical experts
• Access to start-up nation: globally leading high-tech and
• Internal innovation efforts contributing to profitability
• Flexibility to grow organically and through M&A


(1) See non-GAAP financial measures in appendix. 2021 adjusted EBITDA is calculated based on adjusted operating income, net of depreciation and amortization.
Contact [email protected]for more information on ICL View our new interactive data tool athttps://www.icl-group.com/investors/interactive-data-tool/
































| US\$M | 4Q'20 | 4Q'19 | FY'20 | FY'19 |
|---|---|---|---|---|
| Liabilities(1) | \$2,750 | \$2,520 | \$2,800 | \$2,700 |
| Interest rate | 3.9% | 4.2% | 3.8% | 4.2% |
| Interest expenses | \$27 | \$27 | \$107 | \$114 |
| Interest capitalization | (\$7) | (\$6) | (\$24) | (\$19) |
| Interest expenses, net | \$20 | \$21 | \$83 | \$95 |
| Total hedging transactions, balance sheet revaluation |
(\$11) | \$1 | \$20 | (\$18) |
| Interest and exchange rate impact on long term liabilities of leasing and employees and other |
\$37 | \$3 | \$55 | \$52 |
| Net financial expenses | \$46 | \$25 | \$158 | \$129 |

| US\$M | 4Q'20 | 4Q'19 | FY'20 | FY'19 |
|---|---|---|---|---|
| Adjusted income before tax(1) |
\$98 | \$63 | \$356 | \$632 |
| Normalized tax rate |
20% | 22% | 20% | 21% |
| Normalized tax expenses |
\$19 | \$14 | \$72 | \$131 |
| Carryforward losses not recorded for tax purposes |
(\$2) | (\$1) | \$0 | \$2 |
| Exchange rate impact and otheritems | \$8 | \$2 | \$13 | \$14 |
| Adjusted tax expenses |
\$25 | \$15 | \$85 | \$147 |
| Adjusted effective tax rate |
26% | 21% | 24% | 23% |
| Taxadjustments | (\$1) | - | (\$60) | - |
| Reported provision for income taxes |
\$24 | \$15 | \$25 | \$147 |
(1) See detailed reconciliation table – Adjustments to reported operating and net income (Non-GAAP) – in corresponding quarters' earnings release. Note: Numbers may not add, due to rounding and set-offs.
| Calculation of adjusted income before tax US\$M |
4Q'20 | 4Q'19 | FY'20 | FY'19 |
|---|---|---|---|---|
| Adjusted operating income(1) | \$143 | \$88 | \$509 | \$760 |
| Finance expenses |
(\$46) | (\$25) | (\$158) | \$129 |
| Share in earnings (losses) of equity-accounted investees and adjustments to financial expenses | \$1 | - | \$5 | \$1 |
| Adjusted income before tax | \$98 | \$63 | \$356 | \$632 |
| Calculation of segment EBITDA and margin | Industrial Products |
Potash | Phosphate Solutions |
Solutions | Innovative Ag | |||
|---|---|---|---|---|---|---|---|---|
| US\$M | 4Q'20 | 4Q'19 | 4Q'20 | 4Q'19 | 4Q'20 | 4Q'19 | 4Q'20 | 4Q'19 |
| Segment profit | \$80 | \$60 | \$40 | \$22 | \$21 | \$1 | \$5 | (\$2) |
| Depreciation and amortization | \$23 | \$18 | \$43 | \$38 | \$54 | \$44 | \$6 | \$6 |
| Segment EBITDA | \$103 | \$78 | \$83 | \$60 | \$75 | \$45 | \$11 | \$4 |
| Segment EBITDA margin | 31% | 27% | 22% | 20% | 15% | 11% | 7% | 3% |

(1) See detailed reconciliation table – Adjustments to reported operating and net income (Non-GAAP) – in corresponding quarters' earnings release. Note: Numbers may not add, due to rounding and set-offs.
| Net debt to adjusted EBITDA US\$M | 4Q'20 |
|---|---|
| Net debt | 2,463 |
| Adjusted EBITDA | 990 |
| Net debt to adjusted EBITDA | 2.5 |
| Calculation of adjusted EBITDA US\$M |
4Q'19 | 1Q'20 | 2Q'20 | 3Q'20 | 4Q'20 | FY'20 | FY'19 |
|---|---|---|---|---|---|---|---|
| Net income attributable to shareholders of the company | \$48 | \$60 | (\$168) | \$54 | \$65 | \$11 | \$475 |
| Financing expenses, net | \$25 | \$52 | \$31 | \$29 | \$46 | \$158 | \$129 |
| Taxes on income | \$15 | \$20 | (\$33) | \$14 | \$24 | \$25 | \$147 |
| Minority and equity profit, net | - | - | \$1 | \$3 | \$4 | \$8 | \$5 |
| Operating income | \$88 | \$132 | (\$169) | \$100 | \$139 | \$202 | \$756 |
| Minority and equity profit, net | - | - | (\$1) | (\$3) | (\$4) | (\$8) | (\$5) |
| Depreciation and amortization | \$113 | \$118 | \$119 | \$123 | \$129 | \$489 | \$443 |
| Adjustments(1) | - | - | \$297 | \$6 | \$4 | \$307 | \$4 |
| Adjusted EBITDA | \$201 | \$250 | \$246 | \$226 | \$268 | \$990 | \$1,198 |


| Calculation of free cash flow US\$M | 4Q'20 | 4Q'19 | FY'20 | FY'19 |
|---|---|---|---|---|
| Cash flow from operations |
\$258 | \$212 | \$804 | \$992 |
| Additions to property, plant and equipment, and dividends from equity-accounted investees(1) | (\$178) | (\$155) | (\$616) | (\$546) |
| Free cash flow | \$80 | \$57 | \$188 | \$446 |
(1) Also includes proceeds from sale of Property, Plants and Equipment (PP&E).
(2) See detailed reconciliation table – Adjustments to reported operating and net income (Non-GAAP) – in corresponding quarters' earnings release.
Note: Numbers may not add, due to rounding and set-offs.
| Calculation of adjusted net income to income US\$M | 4Q'20 | 4Q'19 | FY'20 | FY'19 |
|---|---|---|---|---|
| Net income attributable to shareholders of the company | \$65 | \$48 | \$11 | \$475 |
| Total adjustments to operating income(2) | \$4 | - | \$307 | \$4 |
| Adjustments to finance expenses(2) | - | - | - | - |
| Total tax impact of above operating income and finance expenses adjustments(2) | (\$1) | - | (\$60) | - |
| Total adjusted net income -shareholders of the company | \$68 | \$48 | \$258 | \$479 |
| Calculation of adjusted operating income US\$M | 4Q'20 | 4Q'19 | FY'20 | FY'19 |
|---|---|---|---|---|
| Operating income | \$139 | \$88 | \$202 | \$756 |
| Impairment loss (reversal), provision for site closure and restoration costs | \$4 | \$7 | \$229 | (\$3) |
| Provision for early retirement | - | - | \$78 | - |
| Provision for prior legal proceedings | - | (\$7) | - | \$7 |
| Total adjustments | \$4 | - | \$307 | \$4 |
| Adjusted operating income | \$143 | \$88 | \$509 | \$760 |
The company only provides guidance on a non-GAAP basis. We do not provide a reconciliation of forward-looking adjusted EBITDA (non-GAAP) to GAAP net income (loss), due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation, in particular because special items such as restructuring, litigation and other matters, used to calculate projected net income (loss) vary dramatically based on actual events, the company is not able to forecast on a GAAP basis with reasonable certainty all deductions needed in order to provide a GAAP calculation of projected net income (loss) at this time. The amount of these deductions may be material and, therefore, could result in projected GAAP net income (loss) being materially less than projected adjusted EBITDA (non-GAAP). Our guidance speaks only as of the date hereof. We undertake no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.
We disclose in this presentation non-IFRS financial measures titled, adjusted operating income, adjusted net income attributable to the Company's shareholders, adjusted EBITDA, adjusted EPS, segment EBITDA, segment EBITDA margin and free cash flow. Our management uses such non-GAAP measures to facilitate operating performance comparisons from period to period and present free cash flow to facilitate a review of our cash flows. We calculate our adjusted operating income by adjusting our operating income to add certain items, as set forth above and in the reconciliation table "Adjustments to reported operating and net income". Certain of these items may recur. We calculate our adjusted net income attributable to the Company's shareholders by adjusting our adjusted operating income, net income attributable to the Company's shareholders to add certain items, as set forth above and in the reconciliation table "Adjustments to reported operating and net income (Non-GAAP)" in the accompanying pressrelease, excluding the total tax impact of such adjustments and adjustments attributable to the non-controlling interests. We calculate our adjusted EBITDA by adding back to the adjusted operating income the depreciation and amortization. Adjusted EPS is calculated as adjusted net income divided by weighted-average diluted number of ordinary shares outstanding as provided in the reconciliation table under "Calculation of Adjusted EPS". We calculate our segment EBITDA by adding back to our segment profit the depreciation and amortization for each segment. We calculate our segment EBITDA margin by dividing segment EBITDA by revenue. We calculate our free cash flow as our cash flows from operating activities net of our purchase of property, plant, equipment and intangible assets, and adding Proceeds from sale of property, plant and equipment and dividends from equity-accounted investees during such period as presented in the reconciliation table under "Calculation of free cash flow". You should not view adjusted operating income, adjusted net income attributable to the Company's shareholders, adjusted EPS or adjusted EBITDA as a substitute for operating income or net income attributable to the Company's shareholders determined in accordance with IFRS, adjusted EPS as a substitute for EPS or free cash flow as a substitute for, cash flows from operating activities and cash flows used in investing activities, and you should note that our definitions of adjusted operating income, adjusted net income attributable to the Company's shareholders, adjusted EBITDA and free cash flow may differ from those used by other companies. However, we believe that such non-GAAP measures provide useful information to both management and investors by excluding certain expenses that management believes are not indicative of our ongoing operations. In particular for free cash flow, we adjust our CAPEX to include any Proceeds from sale of property, plant and equipment because we believe such amounts offset the impact of our purchase of property, plant, equipment and intangible assets. We further adjust free cash flow to add Dividends from equity-accounted investees because receipt of such dividends affects our residual cash flow. Free cash flow does not reflect adjustment for additional items that may impact our residual cash flow for discretionary expenditures, such as adjustments for charges relating to acquisitions, servicing debt obligations, changes in our deposit account balances that relate to our investing activities and other non-discretionary expenditures. Our management uses these non-IFRS measures to evaluate the Company's business strategies and management's performance. We believe that these non-IFRS measures provide useful information to investors because they improve the comparability of the financial results between periods and provide for greater transparency of key measures used to evaluate our performance. We present a discussion in the period-to-period comparisons of the primary drivers of changes in the company's results of operations. This discussion is based in part on management's best estimates of the impact of the main trends in its businesses. We have based the following discussion on our financial statements. You should read the following discussion together with our financial statements.


Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.